Kishan, A. U., Valle, L. F., Wilhalme, H., Felix, C., Nabong, R., Juarez-Casillas, J. E., Flores, K., Ma, T. M., Ludwig, V., Nakayama, M., Ells, Z., Dahlbom, M., Lauria, M., Meyer, C., Cao, M., Weidhaas, J. B., Telesca, D., McGreevy, K., Nickols, N. G., Karasik, D., Parmisano, S., Basehart, T. V., Brisbane, W., Marks, L., Rettig, M. B., Reiter, R. E., Boutros, P. C., Allen-Auerbach, M., Czernin, J., Steinberg, M. L., Calais, J. (2025). <sup>177</sup>
                    Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01553